Postoperative Infection Risk in Total Joint Arthroplasty is
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Perioperative corticosteroid administration is associated with reduced postoperative nausea, pain, and enhanced recovery after surgery. However, potential complications including wound and periprosthetic joint infections remain a concern for surgeons after total joint arthroplasty (TJA).

A systematic search was performed to find comparative studies evaluating infection risk after perioperative corticosteroid administration in TJA. The PRISMA guidelines were followed in this report. Meta-analysis was used to determine infection risk in relation to the joint and corticosteroid dosing regimen.

--201 studies were returned after initial search strategy, with 29 included for review after application of inclusion and exclusion criteria.

--Studies were categorized as using low- or high-dose corticosteroid with single or repeat dosing regimens.

--Single low-dose corticosteroid administration was not associated with an increased risk of infection. Single high-dose corticosteroid was not associated with an increased infection risk nor did repeat low-dose regimens result in increased risk of infection.

--Studies assessing repeat high-dosing regimens reported no increased infection, with small numbers of participants included.

--No significant risk difference in infection risk was noted in hip or knee arthroplasty. Heterogeneity in patient profiles included in studies to date was noted.

Conclusively, Use of perioperative corticosteroid in TJA does not appear to be associated with increased risk of postoperative infection in patients with limited comorbidities.